{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:43:07Z","timestamp":1785825787999,"version":"3.56.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"16-17","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007684","name":"Ministry of Education and Science of Ukraine","doi-asserted-by":"publisher","award":["III 41004"],"award-info":[{"award-number":["III 41004"]}],"id":[{"id":"10.13039\/501100007684","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.clinbiochem.2012.06.012","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T17:18:20Z","timestamp":1340126300000},"page":"1362-1367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia"],"prefix":"10.1016","volume":"45","author":[{"given":"Hellinida","family":"Thomadaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos V.","family":"Floros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Tosic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Gourgiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Colovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Scorilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0005","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","article-title":"Acute myeloid leukemia","volume":"341","author":"Lowenberg","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0010","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.leukres.2007.08.019","article-title":"Increased C-kit intensity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AML","volume":"32","author":"Advani","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0015","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2004-08-2977","article-title":"Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222","volume":"105","author":"Moore","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/sj.leu.2402340","article-title":"High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML)","volume":"16","author":"Kohler","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0025","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/geno.2000.6455","article-title":"Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family","volume":"72","author":"Scorilas","year":"2001","journal-title":"Genomics"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2012.04.084","article-title":"Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells","author":"Kontos","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0035","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1073\/pnas.0712034105","article-title":"Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma","volume":"105","author":"Stegh","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0040","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.febslet.2009.04.011","article-title":"HSP70 protects BCL2L12 and BCL2L12A from N-terminal ubiquitination-mediated proteasomal degradation","volume":"583","author":"Yang","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0045","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3892\/ijo_00000241","article-title":"A natural antisense transcript, BOKAS, regulates the pro-apoptotic activity of human Bok","volume":"34","author":"Zhang","year":"2009","journal-title":"Int J Oncol"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0050","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1515\/BC.2004.101","article-title":"Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer","volume":"385","author":"Mathioudaki","year":"2004","journal-title":"Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0055","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1515\/BC.2008.173","article-title":"Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer","volume":"389","author":"Kontos","year":"2008","journal-title":"Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0060","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1055\/s-0037-1613411","article-title":"Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors","volume":"89","author":"Talieri","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2006.03.016","article-title":"Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer","volume":"247","author":"Thomadaki","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0070","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bbrc.2009.11.034","article-title":"Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer","volume":"391","author":"Florou","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0075","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1101\/gad.1480007","article-title":"Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma","volume":"21","author":"Stegh","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2119\/molmed.2010.00056","article-title":"BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma","volume":"17","author":"Fendri","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0085","article-title":"Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma","author":"Geomela","year":"2012","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0090","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1634\/theoncologist.2010-0349","article-title":"The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker","volume":"16","author":"Papageorgiou","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0095","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1515\/BC.2006.203","article-title":"Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells","volume":"387","author":"Floros","year":"2006","journal-title":"Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1196\/annals.1299.025","article-title":"Cisplatin-induced apoptosis in HL-60 human promyelocytic leukemia cells: differential expression of BCL2 and novel apoptosis-related gene BCL2L12","volume":"1010","author":"Floros","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0105","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0110","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/sj.bjc.6605654","article-title":"Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma","volume":"102","author":"Kontos","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0115","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1182\/blood-2006-06-001149","article-title":"Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?","volume":"109","author":"Mrozek","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0120","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(06)69780-8","article-title":"Acute myeloid leukaemia","volume":"368","author":"Estey","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0125","first-page":"1911","article-title":"Internal tandem duplication of the flt3 gene found in acute myeloid leukemia","volume":"10","author":"Nakao","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0130","first-page":"4277","article-title":"ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements","volume":"54","author":"Schichman","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0135","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1182\/blood.V91.8.2961.2961_2961_2968","article-title":"Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance","volume":"91","author":"King-Underwood","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/85820","article-title":"Dominant-negative mutations of CEBPA, encoding CCAAT\/enhancer binding protein-alpha (C\/EBPalpha), in acute myeloid leukemia","volume":"27","author":"Pabst","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0145","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1182\/blood-2008-04-153239","article-title":"A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects","volume":"113","author":"Wouters","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0150","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/blood-2004-12-4633","article-title":"Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction","volume":"108","author":"Wilson","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0155","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1200\/JCO.2005.01.6253","article-title":"BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications","volume":"24","author":"Baldus","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0160","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/blood-2006-04-014845","article-title":"High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics","volume":"108","author":"Heuser","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0165","doi-asserted-by":"crossref","first-page":"9234","DOI":"10.1200\/JCO.2005.03.6137","article-title":"Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study","volume":"23","author":"Marcucci","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0170","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1620\/tjem.219.169","article-title":"WT1 mRNA level in peripheral blood is a sensitive biomarker for monitoring minimal residual disease in acute myeloid leukemia","volume":"219","author":"Sakamoto","year":"2009","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0175","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1182\/blood-2002-06-1714","article-title":"Amount of spontaneous apoptosis detected by Bax\/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)","volume":"101","author":"Del Poeta","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0180","first-page":"1401","article-title":"BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia","volume":"6","author":"Kornblau","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0185","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1182\/blood.V92.9.3090","article-title":"Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia","volume":"92","author":"Estrov","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0190","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1182\/blood.V81.11.3091.3091","article-title":"High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy","volume":"81","author":"Campos","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0195","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/sj.leu.2400854","article-title":"High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate","volume":"11","author":"Lauria","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0200","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1534\/genetics.106.069484","article-title":"Transcriptional interferences in cis natural antisense transcripts of humans and mice","volume":"176","author":"Osato","year":"2007","journal-title":"Genetics"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0205","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s13277-010-0047-3","article-title":"Quantitative analysis of BCL2 mRNA expression in nasopharyngeal carcinoma: an unfavorable and independent prognostic factor","volume":"31","author":"Fendri","year":"2010","journal-title":"Tumour Biol"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0210","doi-asserted-by":"crossref","first-page":"17926","DOI":"10.1074\/jbc.273.28.17926","article-title":"A potent cell death activity associated with transient high level expression of BCL-2","volume":"273","author":"Uhlmann","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0215","doi-asserted-by":"crossref","first-page":"20898","DOI":"10.1074\/jbc.M011641200","article-title":"In vitro selection and characterization of Bcl-X(L)-binding proteins from a mix of tissue-specific mRNA display libraries","volume":"276","author":"Hammond","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0220","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.4161\/cc.7.18.6759","article-title":"What drives intense apoptosis resistance and propensity for necrosis in glioblastoma? A role for Bcl2L12 as a multifunctional cell death regulator","volume":"7","author":"Stegh","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0225","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1101\/gad.1924710","article-title":"Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor","volume":"24","author":"Stegh","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.clinbiochem.2012.06.012_bb0230","first-page":"1758","article-title":"The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogenetics","volume":"5","author":"Kornblau","year":"1999","journal-title":"Clin Cancer Res"},{"issue":"Pt 1","key":"10.1016\/j.clinbiochem.2012.06.012_bb0235","first-page":"1","article-title":"Caspases: the executioners of apoptosis","volume":"326","author":"Cohen","year":"1997","journal-title":"Biochem J"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012003062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012003062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:39:41Z","timestamp":1757864381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912012003062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":47,"journal-issue":{"issue":"16-17","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0009912012003062"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.06.012","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}